Logo image of ERF.PA

EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis

Europe - EPA:ERF - FR0014000MR3 - Common Stock

58.34 EUR
-0.72 (-1.22%)
Last: 11/6/2025, 5:29:51 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ERF. ERF was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ERF get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on ERF. This makes ERF very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ERF had positive earnings in the past year.
In the past year ERF had a positive cash flow from operations.
Each year in the past 5 years ERF has been profitable.
Each year in the past 5 years ERF had a positive operating cash flow.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ERF's Return On Assets of 3.54% is in line compared to the rest of the industry. ERF outperforms 44.44% of its industry peers.
ERF has a Return On Equity (8.09%) which is comparable to the rest of the industry.
ERF has a Return On Invested Capital of 9.79%. This is in the better half of the industry: ERF outperforms 77.78% of its industry peers.
ERF had an Average Return On Invested Capital over the past 3 years of 8.70%. This is in line with the industry average of 7.57%.
The 3 year average ROIC (8.70%) for ERF is below the current ROIC(9.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROIC 9.79%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ERF's Profit Margin of 5.44% is on the low side compared to the rest of the industry. ERF is outperformed by 66.67% of its industry peers.
ERF's Profit Margin has improved in the last couple of years.
ERF has a Operating Margin of 15.59%. This is comparable to the rest of the industry: ERF outperforms 50.00% of its industry peers.
ERF's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 23.29%, ERF is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
ERF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

ERF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ERF has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ERF has more shares outstanding
The debt/assets ratio for ERF has been reduced compared to a year ago.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.64 indicates that ERF is not a great score, but indicates only limited risk for bankruptcy at the moment.
ERF has a Altman-Z score of 2.64. This is comparable to the rest of the industry: ERF outperforms 44.44% of its industry peers.
The Debt to FCF ratio of ERF is 5.25, which is a neutral value as it means it would take ERF, 5.25 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ERF (5.25) is better than 66.67% of its industry peers.
ERF has a Debt/Equity ratio of 0.77. This is a neutral value indicating ERF is somewhat dependend on debt financing.
ERF has a worse Debt to Equity ratio (0.77) than 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.25
Altman-Z 2.64
ROIC/WACC1.3
WACC7.52%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.26 indicates that ERF should not have too much problems paying its short term obligations.
ERF's Current ratio of 1.26 is on the low side compared to the rest of the industry. ERF is outperformed by 61.11% of its industry peers.
A Quick Ratio of 1.19 indicates that ERF should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.19, ERF is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.50% over the past year.
Measured over the past years, ERF shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
Looking at the last year, ERF shows a small growth in Revenue. The Revenue has grown by 2.53% in the last year.
Measured over the past years, ERF shows a quite strong growth in Revenue. The Revenue has been growing by 8.78% on average per year.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%

3.2 Future

The Earnings Per Share is expected to grow by 13.34% on average over the next years. This is quite good.
ERF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.27% yearly.
EPS Next Y14.76%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
EPS Next 5Y13.34%
Revenue Next Year5.44%
Revenue Next 2Y5.6%
Revenue Next 3Y6.01%
Revenue Next 5Y7.27%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.21, ERF is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 83.33% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.13. ERF is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 14.45 indicates a correct valuation of ERF.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.35, ERF is valued a bit cheaper.
Industry RankSector Rank
PE 16.21
Fwd PE 14.45
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

88.89% of the companies in the same industry are more expensive than ERF, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ERF is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.55
EV/EBITDA 8.31
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ERF's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ERF has a very decent profitability rating, which may justify a higher PE ratio.
ERF's earnings are expected to grow with 14.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)0.88
EPS Next 2Y14.31%
EPS Next 3Y14.14%

4

5. Dividend

5.1 Amount

ERF has a yearly dividend return of 0.99%, which is pretty low.
ERF's Dividend Yield is rather good when compared to the industry average which is at 0.72. ERF pays more dividend than 83.33% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, ERF's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

The dividend of ERF is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ERF pays out 54.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ERF is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

EPA:ERF (11/6/2025, 5:29:51 PM)

58.34

-0.72 (-1.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-21 2025-10-21
Earnings (Next)01-28 2026-01-28/amc
Inst Owners37.21%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.63B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts68.89
Price Target64.78 (11.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.48%
PT rev (3m)7.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.52%
Valuation
Industry RankSector Rank
PE 16.21
Fwd PE 14.45
P/S 1.54
P/FCF 13.55
P/OCF 8.08
P/B 2.29
P/tB N/A
EV/EBITDA 8.31
EPS(TTM)3.6
EY6.17%
EPS(NY)4.04
Fwd EY6.92%
FCF(TTM)4.3
FCFY7.38%
OCF(TTM)7.22
OCFY12.37%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.1
PEG (5Y)0.88
Graham Number45.4
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROCE 12.64%
ROIC 9.79%
ROICexc 10.74%
ROICexgc 34.1%
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
FCFM 11.37%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.25
Debt/EBITDA 2.1
Cap/Depr 84.94%
Cap/Sales 7.7%
Interest Coverage 9.93
Cash Conversion 77.37%
Profit Quality 209.21%
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 2.64
F-Score7
WACC7.52%
ROIC/WACC1.3
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.76%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
EPS Next 5Y13.34%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.44%
Revenue Next 2Y5.6%
Revenue Next 3Y6.01%
Revenue Next 5Y7.27%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year86.11%
EBIT Next 3Y30.34%
EBIT Next 5Y22%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%

EUROFINS SCIENTIFIC / ERF.PA FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ERF.PA.


Can you provide the valuation status for EUROFINS SCIENTIFIC?

ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Undervalued.


Can you provide the profitability details for EUROFINS SCIENTIFIC?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 6 / 10.


How financially healthy is EUROFINS SCIENTIFIC?

The financial health rating of EUROFINS SCIENTIFIC (ERF.PA) is 5 / 10.


Is the dividend of EUROFINS SCIENTIFIC sustainable?

The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 4 / 10 and the dividend payout ratio is 54.91%.